• Mechanistic Insights into Gepotidacin vs. Fluoroquinolone Gy

  2026-05-19

  Gibson et al. characterize the unique mechanism of gepotidacin, a novel bacterial topoisomerase inhibitor, against Staphylococcus aureus DNA gyrase. Their structural and biochemical findings reveal distinct cleavage profiles compared to fluoroquinolones, informing antibiotic design and resistance research.

• JAK Inhibitors Block RA Synovial Fluid-Induced Sensory Neuro

  2026-05-18

  This study demonstrates that JAK inhibitors directly suppress sensory neuron activation triggered by rheumatoid arthritis (RA) synovial fluid, offering mechanistic insight into their superior analgesic effects. Using human IPSC-derived sensory neurons, the authors show that JAK/STAT pathway cytokines in RA synovial fluid induce pain-related signaling, which is abrogated by tofacitinib.

• AIBP–LRP2–HDL Axis Regulates CXCR4+ Capillary Expansion in I

  2026-05-18

  Zhu et al. reveal a two-phase mechanism by which AIBP, through LRP2-mediated HDL uptake, restricts CXCR4+ stem-like capillary endothelial cell (CEC) expansion and collateral vessel formation in ischemic tissues. These findings clarify the molecular regulation of collateral circulation and suggest new therapeutic avenues for vascular remodeling in peripheral artery disease.

• Gene Expression Profiles Predict Olaparib Susceptibility in

  2026-05-17

  Borchert et al. (2019) demonstrate that homologous recombination repair (HRR) gene expression profiles, especially those reflecting BRCAness phenotypes such as BAP1 mutations, predict susceptibility to Olaparib in malignant pleural mesothelioma (MPM) cell lines. This work identifies new prognostic markers and supports targeted PARP inhibitor therapy for a subset of MPM patients.

• NBC19: Enhancing Reproducibility in NLRP3 Inflammasome Assay

  2026-05-16

  This article delivers an evidence-based, scenario-driven analysis of NBC19 (SKU BA6129) as a robust NLRP3 inflammasome inhibitor for inflammation research. By addressing common assay pitfalls and benchmarking NBC19 against alternative solutions, the piece demonstrates NBC19's value in workflow reproducibility and IL-1β release inhibition for biomedical researchers.

• Type III Collagen Restricts Tumor Progression in Breast Canc

  2026-05-15

  This study demonstrates that type III collagen (Col3) in the breast cancer microenvironment plays a tumor-restrictive role, with higher Col3:Col1 ratios correlating with better patient outcomes. The findings offer actionable directions for developing therapies that modulate extracellular matrix composition to limit tumor progression and metastasis.

• MTT as a Quantitative Probe: Redefining Cellular Metabolism

  2026-05-15

  Explore the nuanced biochemistry of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) as a quantitative in vitro cell proliferation assay reagent. This article delivers a mechanistic deep dive and practical assay guidance, connecting mitochondrial redox biology with the latest findings in drug resistance.

• FOXM1–ERα ceRNA Network as a Biomarker Axis in Female LUAD

  2026-05-14

  The referenced study systematically dissects the role of FOXM1 and its ceRNA network with estrogen receptor alpha (ERα) in female lung adenocarcinoma (LUAD). By integrating transcriptomic, bioinformatic, and cellular validation methods, it establishes the prognostic and mechanistic relevance of the DGCR-5—has-miRNA-204-5p—FOXM1—ERα network for LUAD progression and immunotherapy sensitivity.

• PD 0332991 (Palbociclib) HCl: Reliable CDK4/6 Inhibition for

  2026-05-14

  This article examines the practical challenges of cell viability and proliferation assays, demonstrating how PD 0332991 (Palbociclib) HCl (SKU A8316) from APExBIO delivers reproducible, data-backed CDK4/6 inhibition. Scenario-driven Q&A blocks address real experimental design, protocol optimization, and vendor selection concerns, supporting researchers with evidence-based parameters and workflow insights.

• ER Stress and Cytokine Storm Induce Metastatic States in Tum

  2026-05-13

  This study reveals that tumor cells surviving near-death experiences, such as apoptosis, can develop stable prometastatic states driven by ER stress, reprogramming, and a cytokine storm. The findings provide a mechanistic link between cell-death-inducing therapies and the paradoxical promotion of metastasis, highlighting new targets for intervention in cancer progression.

• IgSF6 Deficiency Enhances Antibacterial Defense via ER Stres

  2026-05-13

  This study uncovers a pivotal role for the ER-localized immunoglobulin IgSF6 in regulating endoplasmic reticulum (ER) stress and inflammatory responses in intestinal macrophages. By demonstrating that Igsf6 deficiency enhances bactericidal activity through modulation of the IRE1α-XBP1 pathway and reactive oxygen species generation, the research provides new mechanistic insights into intestinal immune homeostasis and antibacterial defense.

• EdU Imaging Kits (HF488): High-Fidelity Cell Proliferation I

  2026-05-12

  Explore how EdU Imaging Kits (HF488) deliver unparalleled accuracy in cell proliferation assays using 5-ethynyl-2'-deoxyuridine, with advanced click chemistry and recent mechanistic findings offering new standards for quantitative analysis.

• Axitinib (AG 013736): Quantitative Insights for Advanced VEG

  2026-05-12

  Explore the advanced scientific rationale and quantitative application of Axitinib (AG 013736) in angiogenesis inhibition and tumor growth assays. This article reveals how nuanced in vitro metrics and selectivity profiles can transform VEGF signaling pathway research.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-05-11

  The AO/PI Double Staining Kit enables rapid, fluorescence-based discrimination of viable, apoptotic, and necrotic cells in cultured samples. It is optimal for researchers requiring straightforward, single-assay assessment of cell health but is not suitable for tissue section analysis or workflows lacking fluorescence imaging capability.

• DFCP1 Regulates Starvation-Driven ATGL Activity in Lipid Dro

  2026-05-11

  This study uncovers Double FYVE Domain Containing Protein 1 (DFCP1) as a nutrient-sensitive regulator of lipid droplet lipolysis, acting through direct modulation of ATGL during cellular starvation. These findings clarify the mechanisms controlling lipid mobilization under metabolic stress, providing a foundation for improved metabolic disease research and advanced protein complex stability protocols.

16155 records 1/1077 page Next 12345 下5页 Last page